The effects of lowering uric acid levels using allopurinol on components of Metabolic Syndrome.
dc.contributor.advisor | Bowden, Rodney G., 1966- | |
dc.contributor.author | Heimbach, Esther J. | |
dc.contributor.department | Health, Human Performance and Recreation. | en |
dc.contributor.other | Baylor University. Dept. of Health, Human Performance and Recreation. | en |
dc.date.accessioned | 2011-05-12T15:36:27Z | |
dc.date.available | 2011-05-12T15:36:27Z | |
dc.date.copyright | 2011-05 | |
dc.date.issued | 2011-05-12T15:36:27Z | |
dc.description.abstract | Purpose: To determine the relationship between uric acid and lipid levels for the purpose of understanding more about the public health issue of Metabolic Syndrome. Methods: A retrospective analysis was conducted using 66 patients from a family health clinic who were over the age of 18 and who had been given at least three prescriptions of allopurinol. Repeated measures linear growth models with Restricted Maximum Likelihood tests were conducted to determine the relationship of uric acid and the lipid levels. Results: A significant relationship between uric acid and lipid levels was not determined. There was a slight indication of a relationship between uric acid and total cholesterol or HDL-cholesterol. Uric acid levels did not decrease over time for all participants as expected. Conclusions: More research is needed to explore the relationship between uric acid and lipid levels. Furthermore, compliance among participants could be enhanced by determining best health education methods. | en |
dc.description.degree | M.P.H. | en |
dc.description.statementofresponsibility | by Esther J. Heimbach. | en |
dc.format.extent | 63798 bytes | |
dc.format.extent | 3008868 bytes | |
dc.format.mimetype | application/pdf | |
dc.format.mimetype | application/pdf | |
dc.identifier.uri | http://hdl.handle.net/2104/8145 | |
dc.language.iso | en_US | en |
dc.rights | Baylor University theses are protected by copyright. They may be viewed from this source for any purpose, but reproduction or distribution in any format is prohibited without written permission. Contact librarywebmaster@baylor.edu for inquiries about permission. | en |
dc.rights.accessrights | Worldwide access. | en |
dc.rights.accessrights | Access changed 9/12/13. | |
dc.subject | Uric acid. | en |
dc.subject | Metabolic Syndrome. | en |
dc.subject | Allopurinol. | en |
dc.subject | Triglycerides. | en |
dc.subject | HDL-cholesterol. | en |
dc.subject | LDL-cholesterol. | en |
dc.subject | Total cholesterol. | en |
dc.subject | Hyperuricemia. | en |
dc.subject | Public health. | en |
dc.subject | Lipid levels. | en |
dc.title | The effects of lowering uric acid levels using allopurinol on components of Metabolic Syndrome. | en |
dc.type | Thesis | en |
Files
License bundle
1 - 1 of 1
No Thumbnail Available
- Name:
- license.txt
- Size:
- 1.96 KB
- Format:
- Item-specific license agreed upon to submission
- Description: